Wednesday, June 25, 2025
VISIT ROYALMOK
Agarwood Times
  • Home
  • Agarwood
  • Health
  • Diseases
  • Diet & Fitness
  • Nutrition
  • Sleep Info
  • Meditation
  • Shop
No Result
View All Result
  • Home
  • Agarwood
  • Health
  • Diseases
  • Diet & Fitness
  • Nutrition
  • Sleep Info
  • Meditation
  • Shop
No Result
View All Result
Agarwood Times
No Result
View All Result

Readout Newsletter: Viridian, Edgewise, Vertex, Novo-Catalent

December 16, 2024
in Health
Reading Time: 3 mins read
0 0
A A
0
Home Health
Share on FacebookShare on Twitter



Need to keep on prime of the science and politics driving biotech as we speak? Enroll to get our biotech e-newsletter in your inbox.

Hi there! Combating again a hyper 6-year-old and his 3-year-old associate in crime as I try to jot down an intro right here. My offspring say good day.

At this time, we focus on the revolutionary method a mom is trying to lift cash for a gene remedy for her baby, we see South African regulators drop their investigation into Vertex’s cystic fibrosis drug Trikafta, and extra.

The necessity-to-know this morning

Edgewise Therapeutics mentioned an experimental drug designed to forestall muscle injury achieved the first purpose of a examine involving individuals with Duchenne muscular dystrophy, a uncommon neuromuscular dysfunction. The Edgewise drug considerably diminished a blood-based biomarker for muscle loss in comparison with placebo. Muscle-function assessments confirmed enhancements, though the outcomes weren’t statistically important.
Neurocrine Biosciences received FDA approval for a drug to deal with basic congenital adrenal hyperplasia, a uncommon illness involving the adrenal glands. The drug might be marketed below the model title Crenessity.
Abbvie acquired privately held Nimble Therapeutics for $200 million. Nimble is growing medicine for autoimmune illnesses.

Because the drug business’s curiosity in gene remedy fades, one household takes an uncommon strategy

Gene remedy, in principle, may very well be harnessed to deal with every kind of uncommon illnesses. However too usually these circumstances are so uncommon that they fail to seize the curiosity of the drug business.

Amber Freed, a mom whose 7-year-old son has a uncommon genetic situation and would possibly profit from gene remedy, has provide you with a artistic answer: She hopes to lift $1 million to fund the manufacturing of a therapy in addition to early trials — and is providing to call the therapy after the highest-bidding donor.

“If we’re in a position to title the therapy after a funder, it’s really a approach to honor an individual’s title ceaselessly,” mentioned Freed, who was a monetary analyst earlier than she give up her job to chase a treatment for the ultra-rare illness Maxwell has, SLC6A1. “You’re going to be saving lives and serving to youngsters and a reputation can ceaselessly be related to grit and perseverance.”

Learn extra.

Viridian confirms advantage of drug for thyroid eye illness

An experimental therapy from Viridian Therapeutics improved the indicators and signs of continual thyroid eye illness — reaching the objectives of a second Part 3 scientific trial, the corporate reported as we speak.

Within the 15-week examine, 56% of individuals responded to therapy with Viridian’s drug, known as veligrotug, in comparison with 8% within the placebo group. Response was outlined as a significant discount in eye bulging, a trademark signal of thyroid eye illness. Listening to impairment, a carefully watched aspect impact, was reported by 13% of the individuals handled with veligrotug in comparison with 3% within the placebo arm.

In September, veligrotug, previously referred to as VRDN-001, achieved the objectives of a Part 3 examine in individuals with energetic thyroid eye illness. Viridian will embrace the outcomes of each research in its advertising and marketing software to the FDA,  anticipated within the second half of 2025.

Veligrotug is an antibody that targets insulin-like development factor-1 receptor. It’s based mostly on the identical mechanism as Amgen’s Tepezza, which was accepted for thyroid eye illness in 2020 and is anticipated to generate almost $1 billion in gross sales this 12 months.

FTC declines to problem Novo-Catalent deal

Novo Holdings will finalize its $16.5 billion acquisition of the contract drug producer Catalent within the coming days, after months of scrutiny from regulators, together with the FTC.

The acquisition was prompted by sporadic shortages of one of many world’s hottest-selling medicines — Novo Nordisk’s weight reduction therapy Wegovy — and designed, partially, to unravel what has been a important and seemingly intractable drawback for Novo Nordisk.

However the prospect that Novo Holdings would possibly quickly management one of many largest gamers in pharmaceutical contract work prompted hypothesis that the FTC would object on anti-competitive grounds.

Learn extra.

South Africa: Vertex has offered enough entry to cystic fibrosis therapy

South African regulators have concluded that Vertex Prescribed drugs is providing enough entry to its cystic fibrosis therapy Trikafta. Its conclusion ends a high-profile investigation into the corporate’s dealings there — at the same time as advocacy teams insist extra must be performed.

Vertex has made Trikafta accessible through non-public well being plans and a affected person help program, however critics say that solely sufferers with premium medical protection can entry it.

Learn extra.

Extra reads

Ozempic hyperlink to uncommon imaginative and prescient loss danger confirmed in examine, Bloomberg



Source link

Tags: EdgewisenewsletterNovoCatalentReadoutVertexViridian
Previous Post

10-Minute Guided Incredible Aura-Cleansing Meditation

Next Post

New guidelines unveil advanced strategies for HIV treatment and prevention

Related Posts

Prenatal air pollution exposure linked to higher childhood obesity risk
Health

Prenatal air pollution exposure linked to higher childhood obesity risk

June 25, 2025
The Hospital Word Has Become a Tale of the Haves and Have-Nots
Health

The Hospital Word Has Become a Tale of the Haves and Have-Nots

June 25, 2025
Emotional demands and confrontation in person-contact roles linked to heightened type 2 diabetes risk
Health

Emotional demands and confrontation in person-contact roles linked to heightened type 2 diabetes risk

June 25, 2025
Global progress on childhood vaccinations is slowing down
Health

Global progress on childhood vaccinations is slowing down

June 25, 2025
5 takeaways from health insurers’ new pledge to improve prior authorization
Health

5 takeaways from health insurers’ new pledge to improve prior authorization

June 24, 2025
RFK Jr Admits He ‘Did Not Fact Check’ MAHA Report Before Non-Existent Sources Were Found in the Paper
Health

RFK Jr Admits He ‘Did Not Fact Check’ MAHA Report Before Non-Existent Sources Were Found in the Paper

June 25, 2025
Next Post
New guidelines unveil advanced strategies for HIV treatment and prevention

New guidelines unveil advanced strategies for HIV treatment and prevention

AASM advocates for permanent sleep telehealth services

AASM advocates for permanent sleep telehealth services

Top Health, Wellness, and Fitness Trends for 2025

Top Health, Wellness, and Fitness Trends for 2025

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

RECOMMENDED

Analysis highlights bacterial contamination, multidrug-resistance, in retail meat samples
Diseases

Analysis highlights bacterial contamination, multidrug-resistance, in retail meat samples

by admin
June 19, 2025
0

nastya_ph / iStock Over one-third of US retail meat samples examined optimistic for no less than one kind of doubtless...

Indian agar wood #bakhoor #hindioudh #wholesale #wood #india #market #business #love #agarwood #@&?🌍

Indian agar wood #bakhoor #hindioudh #wholesale #wood #india #market #business #love #agarwood #@&?🌍

June 25, 2025
35 Best Soy Dinner Recipes – Healthy Plant-Based Meals with Tofu, Tempeh, Edamame & More

35 Best Soy Dinner Recipes – Healthy Plant-Based Meals with Tofu, Tempeh, Edamame & More

June 23, 2025
The Overlooked Global Warming Cost We Can’t Ignore

The Overlooked Global Warming Cost We Can’t Ignore

June 23, 2025
Novo Nordisk’s next-gen obesity drug results a letdown for investors

Novo Nordisk’s next-gen obesity drug results a letdown for investors

June 22, 2025
Oud – The Most expensive perfumery ingredient on Earth 😱

Oud – The Most expensive perfumery ingredient on Earth 😱

June 21, 2025
Facebook Twitter Instagram Youtube RSS
Agarwood Times

Stay informed with the latest news, articles, and insights on agarwood cultivation, history, sustainability, and more. Explore the timeless allure of agarwood and deepen your understanding of this extraordinary natural resource.

CATEGORIES

  • Agarwood
  • Diet & Fitness
  • Diseases
  • Health
  • Meditation
  • Nutrition
  • Sleep Info
  • Uncategorized
No Result
View All Result

SITEMAP

  • About us
  • Advertise With Us
  • Disclaimer
  • Privacy Policy
  • DMCA
  • Cookie Privacy Policy
  • Terms and Conditions
  • Contact us

Copyright © 2024 Agarwood Times.
Agarwood Times is not responsible for the content of external sites.

No Result
View All Result
  • Home
  • Agarwood
  • Health
  • Diseases
  • Diet & Fitness
  • Nutrition
  • Sleep Info
  • Meditation
  • Shop
VISIT ROYALMOK

Copyright © 2024 Agarwood Times.
Agarwood Times is not responsible for the content of external sites.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In